Lonza Clonetics HSeC-Human Sertoli cells

Monday, 11 October, 2010 | Supplied by: Lonza Australia Pty Ltd

Clonetics HSeC-Human Sertoli Cells are an asset to research involving male infertility and reproductive toxicology, xeno/allograft cotransplantation, immune suppression and many other applications.

Sertoli cells are highly specialised and essential for maintenance of testicular homeostasis and male reproductive viability.

QC characterisation of Sertoli cells includes testing for cellular proteins, seeding efficiency, doubling time and morphology and 70% confluence by day 12 in culture. Cells test positive for GATA-4 and Sox-9 at > 70% by flow cytometry.

Cells test negative for mycoplasma, bacteria, yeast and fungi. HIV-1 and Hepatitis B/C are not detected for all donors and/or cell lots.

A Certificate of Analysis is provided for each cell lot purchased.

Clonetics cells are guaranteed to perform as indicated when used with Clonetics Media and Reagents

Online: www.lonza.com
Phone: 03 9550 0883
Related Products

AdipoGen Life Sciences tubulin products for neurodegeneration research

AdipoGen Life Sciences offers a broad range of microtubule research solutions. This includes...

SYnAbs monoclonal antibodies

SYnAbs produces innovative monoclonal antibodies against poor immunogenic compounds and complex...

Merck VirusExpress Lentiviral Production Platform

The platform helps to overcome lentiviral production challenges and can reduce process...

  • All content Copyright © 2020 Westwick-Farrow Pty Ltd